SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-24-000083
Filing Date
2024-09-20
Accepted
2024-09-20 16:19:26
Documents
17
Period of Report
2024-09-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20240920.htm   iXBRL 8-K 36313
2 EX-99.1 a2024q3exhibit991talc1.htm EX-99.1 20115
7 image_0a.jpg GRAPHIC 244
8 image_1a.jpg GRAPHIC 19328
  Complete submission text file 0000200406-24-000083.txt   285109

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20240920.xsd EX-101.SCH 3800
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20240920_def.xml EX-101.DEF 8616
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20240920_lab.xml EX-101.LAB 33327
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20240920_pre.xml EX-101.PRE 20041
19 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20240920_htm.xml XML 7715
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 241313624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)